Autoinflammatory Disease during Covid-19 Epidemiological investigation of COVID-19 in autoinflammatory diseases. Protected confidentiality. Do You agree? OK Question Title * 1. Identity M (male) F (female) OK Question Title * 2. Age OK Question Title * 3. Date of Covid-19 diagnosis Date Data OK Question Title * 4. Autoinflammatory disease Familial Mediterranean Fever TRAPS Cryopyrin-associated periodic syndrome- CAPS Hyper IgD syndrome - Mevalonate kinase deficiency Still's disease Recurrent pericarditis PFAPA (periodic fever, aphthous stomatitis, adenitis) Other (specify) for more information visit the web site: http://rita.ern-net.eu//rare-diseases/#aid-tab OK Question Title * 5. Treatment Colchicine Anakinra - (Kineret) Canakinumab - (Ilaris) Steroids - (prednisone/dexamethasone) None Other (specify ) OK Question Title * 6. Colchicine dose, mg 0.5 1 1.5 2 more than 2 mg (specify) OK Question Title * 7. Symptoms Fever Cough Dyspnea Loss of taste Smell loss Fatigue - Asthenia Muscle aches - myalgia Gastrointestinal symptoms (e.g. diarrhea, nausea) Headache Other (specify) OK Question Title * 8. Severity Fever only >37.5 °C Home isolation with symptomatic treatment Hospitalization less than 1 month Hospitalization over 1 month Hospitalization in the intensive care unit Mechanical ventilation Death Other (specify) OK Question Title * 9. Other diseases Obesity Hypertension Asthma Chronic bronchitis Diabetes mellitus Cardiopathy Other (specify) OK STOP -FINE
